Celcuity Inc. (CELC) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Celcuity Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Celcuity Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Celcuity Inc. actually do?
Answer:
Celcuity Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for solid tumors, with its lead candidate, gedatolisib, a pan-class I PI3K and mTOR inhibitor. Gedatolisib is being evaluated in Phase 3 trials for advanced breast cancer (VIKTORIA-1 and VIKTORIA-2) and a Phase 1b/2 trial for metastatic castration-resistant prostate cancer (CELC-G-201). The company has submitted a New Drug Application (NDA) to the FDA for gedatolisib in advanced breast cancer, which has been accepted for Priority Review with a target decision date in July 2026. Gedatolisib's mechanism of action aims to overcome resistance mechanisms seen with other therapies targeting the PI3K/AKT/mTOR pathway. Celcuity has exclusive worldwide rights to gedatolisib through a license agreement with Pfizer.
Question:
What are Celcuity Inc.'s revenue drivers?
Answer:
Celcuity has not generated revenue to date. Future revenue is expected to be driven by the potential commercialization of its lead drug candidate, gedatolisib, if approved by regulatory authorities.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required